Case ReportOpen Access

Invasive Cystic Hypersecretory Carcinoma of Breast: A Case Report

Volume 2 - Issue 2

**Yao Yongzhong^1,2, Shi Xianbiao¹, Zhao Yixin², You Xin², Wang Jingmei³, Yu Huiping³ and Wang Shouju⁴**

Author Information Open or Close
- ¹Department of Breast Surgery, Medical School of Nanjing University, Nanjing, China
- ²Department of Surgery, Southeast University, Nanjing, China
- ³Department of Pathology, Medical School of Nanjing University, Nanjing, China
- ⁴Department of Medical Imaging, Nanjing University, Nanjing, China
*Corresponding author: Wang Shouju, Department of Medical Imaging, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210000, China

Received: January 23, 2018; Published: February 02, 2018

DOI: 10.26717/BJSTR.2018.02.000720

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Invasive cystic hypersecretory hyperplasia (CHH) of the breast is very rare. The clinical manifestation of CHH iscystic masses, and it is not easy to determine its biological characteristics before an operation. A 54-year-old female patient was admitted with a cystic massin the left breastfor one week. After the operation, the pathology diagnosis was invasive CHC, and the postoperative period was uneventful.

Keywords: Invasive Cystic Hypersecretory Carcinoma (Chc); Breast Cancer; Breast-Conserving Surgery; Palpable Mass

Abbreviation: CHH: Cystic Hypersecretory Hyperplasia; CHC: Cystic Hypersecretory Carcinoma; TG: Thyro Globulin; TTF-1: Thyroid Transcription Factor-1; GATA3: GATA binding protein 3; ER: Estrogen Receptor; PR: Progesterone Receptor; HER-2: Human Epidermal growth factor Receptor-2